What is Wave Life Sciences's revenue?

Wave Life Sciences (WVE) generated $75.8M in revenue over the trailing twelve months, down 32.9% year over year.

Is Wave Life Sciences profitable?

Wave Life Sciences is not currently profitable: it reported a net loss of $183.6M over the trailing twelve months, a -66.5% net margin.

What is Wave Life Sciences's earnings per share?

Wave Life Sciences's diluted EPS over the trailing twelve months is $-1.05.

Where does Wave Life Sciences's income statement data come from?

Every line is extracted from Wave Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Wave Life Sciences WVE Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	——	——	——	——	——
Research and development	$189.6M+3.7%	$182.78M+4.7%	$174.61M+2.8%	$169.93M+1.8%	$166.86M+4.5%
General and administrative	$79.08M+5.0%	$75.33M+6.7%	$70.57M+4.5%	$67.52M+5.8%	$63.83M+8.1%
Other operating expenses	$268.68M+4.1%	$258.11M+5.3%	$245.18M+3.3%	$237.46M+2.9%	$230.69M+5.5%
Total operating expenses	$268.68M+4.1%	$258.11M+5.3%	$245.18M+3.3%	$237.46M+2.9%	$230.69M+5.5%
Operating income	-$196.88M+8.6%	-$215.38M—	——	——	——
Interest income	$12.89M+23.1%	$10.48M-6.1%	$11.16M+3.5%	$10.78M+2.7%	$10.5M+3.3%
Other income (expense), net	$13.29M+20.8%	$11.01M-21.4%	$14M+2.7%	$13.64M+1.6%	$13.42M+0.2%
Income before income taxes	-$183.59M+10.2%	-$204.38M—	——	——	——
Income tax expense	$0—	$0—	$0—	$0—	$0—
Net income	-$183.59M+10.2%	-$204.38M—	——	——	——
Diluted earnings per share	-$1.05+13.2%	-$1.21—	——	——	——
Basic earnings per share	-$1.05+13.2%	-$1.21—	——	——	——
Weighted-average shares, diluted	700.5M+5.7%	662.9M+4.8%	632.6M+5.9%	597.4M+6.1%	562.9M+6.3%
Weighted-average shares, basic	700.5M+5.7%	662.9M+4.8%	632.6M+5.9%	597.4M+6.1%	562.9M+6.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	-$183.64M+10.1%	-$204.37M—	——	——	——
Foreign currency translation gains (losses)	——	——	-$31K-126%	$118K+2,067%	-$6K+95.7%
Other income, net (Note 6)	$396K-24.9%	$527K-81.5%	$2.84M-0.5%	$2.85M-2.2%	$2.92M-9.7%
Revenue From Contract With Customer Excluding Assessed Tax	——	——	——	——	——
EBIT	-$196.88M+8.6%	-$215.38M—	——	——	——
EBITDA	-$193.47M+8.7%	-$211.94M—	——	——	——
EBITDA	-$193.47M+8.7%	-$211.94M—	——	——	——
EBIT	-$196.88M+8.6%	-$215.38M—	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Wave Life Sciences.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Wave Life Sciences's revenue?: Wave Life Sciences (WVE) generated $75.8M in revenue over the trailing twelve months, down 32.9% year over year.
Is Wave Life Sciences profitable?: Wave Life Sciences is not currently profitable: it reported a net loss of $183.6M over the trailing twelve months, a -66.5% net margin.
What is Wave Life Sciences's earnings per share?: Wave Life Sciences's diluted EPS over the trailing twelve months is $-1.05.
Where does Wave Life Sciences's income statement data come from?: Every line is extracted from Wave Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.